drugset
drugset / Trial / NCT03991208

Malarone Pharmacokinetics Under Simulated Physiologic Stressors of Deployment

NCT03991208 ↗

Phase 4 Withdrawn Walter Reed Army Institute of Research (WRAIR)
RandomizedCrossoverOpen-labelTreatment

Summary

A 2x2 randomized crossover of single dose malarone at rest and during moderate intensity exercise under controlled conditions of heat and humidity in healthy adult participants. Statistical analysis of AUC and Cmax will be performed to determine pharmacokinetic changes.

Timeline

Start
2019-05-24
Primary completion
2021-05-23
Completion
2021-05-23

Outcome

Outcome not reported

Stopped (Enrollment): “Unable to recruit”

Drugs

EvaluationDrugModalityDoseRoute
Subject Malarone Unknown — —

Indications

No indication recorded.